What’s Lungs Got to Do With It?

By DocWire News Editors - Last Updated: August 30, 2023

Antiphospholipid syndrome (APS) is a systemic autoimmune disease. It is characterized by recurrent thromboembolic events and/or morbidity in pregnancy in the presence of laboratory evidence of antiphospholipid antibodies (aPL).  

Advertisement

Several lung manifestations may develop in patients with APS, including pulmonary embolismthromboembolic and non-thromboembolic pulmonary hypertensionpulmonary microthrombosis, and more. Although pulmonary manifestations are relatively rare within the realm of aPL, it can happen and is more likely to be life threatening compared to other complications of aPL. In this article in the European Medical Journal, the author discusses the importance of early diagnosis and treatment of pulmonary manifestations, in order to improve morality rates in patients with this type of condition. 

SOURCE: European Medical Journal 

Advertisement